In the present study, our in vitro experiments revealed that CD10+ fibroblasts derived from colon cancer tissues significantly enhanced the invasion of CD133+ colon cancer cells compared with CD10− fibroblasts. This evidence concerns the gene PROM1 and colonic neoplasm.